InvestSMART

Enlitic Inc (ASX: ENL) - Announcements

Current share price for ENL : $0.037 0.033 (825%)+

ASX company news and announcements for Enlitic Inc (ENL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Enlitic Inc (ENL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Enlitic Inc (ENL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Enlitic Inc (ENL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$248 Results of Meeting 4 Feb 2026 12:03PM $0.012 $0.035 risen by 191.67%
$248 Amended Appendix 4C 2 Feb 2026 9:02AM $0.012 $0.035 risen by 191.67%
$248 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 8:29AM $0.014 $0.035 risen by 150%
$248 Notification of cessation of securities - ENL 14 Jan 2026 9:17AM $0.019 $0.035 risen by 84.21%
$248 Notification regarding unquoted securities - ENL 14 Jan 2026 9:14AM $0.019 $0.035 risen by 84.21%
$248 Notice of Extraordinary General Meeting/Proxy Form 14 Jan 2026 8:49AM $0.019 $0.035 risen by 84.21%
$248 Enlitic Completes Technical Validation of Ensight Platform 13 Jan 2026 9:17AM $0.018 $0.035 risen by 94.44%
$248 Notification regarding unquoted securities - ENL 24 Dec 2025 9:59AM $0.022 $0.035 risen by 59.09%
$248 Cleansing Notice 24 Dec 2025 9:59AM $0.022 $0.035 risen by 59.09%
$248 Proposed issue of securities - ENL 24 Dec 2025 9:58AM $0.022 $0.035 risen by 59.09%
$248 Enlitic secures commitments for $8m Convertible Note Raising 24 Dec 2025 9:58AM $0.022 $0.035 risen by 59.09%
$248 Trading Halt 22 Dec 2025 9:23AM $0.022 $0.035 risen by 59.09%
$248 Application for quotation of securities - ENL 18 Dec 2025 9:58AM $0.024 $0.035 risen by 45.83%
$248 Upcoming release of escrowed securities 11 Dec 2025 11:22AM $0.024 $0.035 risen by 45.83%
$248 Expanded Relationship with GE Healthcare 26 Nov 2025 9:25AM $0.033 $0.035 risen by 6.06%
$248 Enlitic Announces Global Partnership with Philips 25 Nov 2025 9:18AM $0.023 $0.035 risen by 52.17%
$248 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2025 9:38AM $0.029 $0.035 risen by 20.69%
$248 Notification of cessation of securities - ENL 7 Oct 2025 5:44PM $0.033 $0.035 risen by 6.06%
$248 Appendix 4D and Half Year Report 27 Aug 2025 4:40PM $0.044 $0.035 fallen by 20.45%
$248 Confirmation of previously stated expectations 31 Jul 2025 8:28AM $0.034 $0.035 risen by 2.94%
$248 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2025 3:14PM $0.031 $0.035 risen by 12.90%
$248 Notification regarding unquoted securities - ENL 11 Jul 2025 4:15PM $0.038 $0.035 fallen by 7.89%
$248 Notification of cessation of securities - ENL 11 Jul 2025 4:13PM $0.038 $0.035 fallen by 7.89%
$248 Completion of Financial Requirements under GE HealthCare MOU 4 Jul 2025 8:31AM $0.030 $0.035 risen by 16.67%
$248 Change of Director's Interest Notice 17 Jun 2025 1:13PM $0.024 $0.035 risen by 45.83%

51 - 75 of 325 results

Page 3 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.